share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Chaguturu Sreekanth K

西維斯健康 | 4：持股變動聲明-高管 Chaguturu Sreekanth K

SEC announcement ·  02/28 22:49
Moomoo AI 已提取核心訊息
CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a sale of 355 shares of common stock on February 26, 2024. The transaction was carried out at a price of $76.43 per share, resulting in a total value of $27,132.65. Following the sale, Chaguturu Sreekanth K's direct holdings in CVS Health amounted to 9,333.9847 shares. The sale was executed as a means to cover the exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a sale of 355 shares of common stock on February 26, 2024. The transaction was carried out at a price of $76.43 per share, resulting in a total value of $27,132.65. Following the sale, Chaguturu Sreekanth K's direct holdings in CVS Health amounted to 9,333.9847 shares. The sale was executed as a means to cover the exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
CVS Health執行副總裁兼首席醫療官Chaguturu Sreekanth K於2024年2月26日完成了355股普通股的出售。該交易以每股76.43美元的價格進行，總價值爲27,132.65美元。出售後，Chaguturu Sreekanth K在CVS Health的直接持股量爲9,333.9847股。如交易代碼 “F” 所示，此次出售是通過交付或預扣證券來彌補行使價或納稅義務的一種手段。
CVS Health執行副總裁兼首席醫療官Chaguturu Sreekanth K於2024年2月26日完成了355股普通股的出售。該交易以每股76.43美元的價格進行，總價值爲27,132.65美元。出售後，Chaguturu Sreekanth K在CVS Health的直接持股量爲9,333.9847股。如交易代碼 “F” 所示，此次出售是通過交付或預扣證券來彌補行使價或納稅義務的一種手段。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息